<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: We investigated the incidence of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), its transfusion requirements, and complications of red blood cell (RBC) transfusion dependence (TD) using a hospitalization data set from a population of 5.3 million </plain></SENT>
<SENT sid="1" pm="."><plain>STUDY DESIGN AND METHODS: This study was a retrospective cohort analysis of a population data set that captures diagnostic and procedure data on <z:hpo ids='HP_0000001'>all</z:hpo> hospitalizations from more than 300 hospitals within the Australian state of Victoria from 1998 to 2008 </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: There were 3149 incident cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The age-standardized incidence rate was higher than reported from <z:e sem="disease" ids="C0796563" disease_type="Neoplastic Process" abbrv="">local cancer</z:e> registries (for 2007 9.6 per 100,000 [95% confidence interval {CI}, 9.2-10.0] vs. 4.8) </plain></SENT>
<SENT sid="4" pm="."><plain>Median age was 79 years, 56.3% were males, and 34.6% were TD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Overall number of hospitalizations with transfusion increased over the study period, but not median transfusion episodes per patient </plain></SENT>
<SENT sid="6" pm="."><plain>TD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was associated with new diagnoses of <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>; incident rate ratio [IRR], 1.92; 95% CI, 1.41-2.60), but not <z:mp ids='MP_0002055'>diabetes</z:mp> (IRR, 1.29; 95% CI, 0.54-3.04) or <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> (IRR, 1.91; 95% CI, 0.63-5.78) </plain></SENT>
<SENT sid="7" pm="."><plain>TD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was associated with <z:mp ids='MP_0001794'>bacterial</z:mp> (IRR, 1.75; 95% CI, 1.37-2.24) and <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e> (IRR, 3.13; 95% CI, 1.70-5.75) and <z:hpo ids='HP_0001909'>leukemia</z:hpo> (relative risk [RR], 1.42; 95% CI, 1.07-1.88) and <z:hpo ids='HP_0100806'>sepsis</z:hpo> as cause of <z:hpo ids='HP_0011420'>death</z:hpo> (RR, 1.23; 95% CI, 1.03-1.47) but not <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> (RR, 0.97; 95% CI, 0.71-1.32) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: There was a higher incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> compared with that reported by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registries </plain></SENT>
<SENT sid="9" pm="."><plain>Overall hospitalizations increased over the study period with no change in transfusion episodes per patient </plain></SENT>
<SENT sid="10" pm="."><plain>There were more incident cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> and <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> in TD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>; however, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> was not a more frequent cause of <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
</text></document>